
On November 6, 2025, several prominent companies are scheduled to report Q3 2025 earnings, presenting a varied outlook for investors. AstraZeneca (AZN) is forecast for a 9.62% EPS increase to $1.14, while Parker-Hannifin (PH) anticipates a 7.58% rise to $6.67, with both showing P/E ratios indicative of superior growth compared to their industries. In contrast, ConocoPhillips (COP) is projected to experience a 21.35% EPS decrease to $1.40, and Vistra (VST) and Warner Bros. Discovery (WBD) face significant expected declines of 77.14% and 180% respectively, highlighting a diverse set of performance expectations across different sectors.
Several companies are set to report Q3 2025 earnings on November 6, 2025, presenting a diverse performance outlook across sectors. Parker-Hannifin (PH) and Rockwell Automation (ROK) stand out with strong consensus EPS growth forecasts of 7.58% and 19.03% year-over-year, respectively, both having consistently beaten expectations in the past year. AstraZeneca (AZN) also projects a solid 9.62% EPS increase, despite a prior quarter miss. Conversely, several firms anticipate significant year-over-year EPS declines, indicating potential operational or market challenges. Vistra Corp. (VST) is forecast for a substantial 77.14% decrease, while Warner Bros. Discovery (WBD) projects a severe 180.00% decline to a negative EPS. Oil sector players ConocoPhillips (COP) and Canadian Natural Resources (CNQ) also face projected EPS reductions of 21.35% and 23.94%, respectively, despite COP's consistent past beats. Zacks Investment Research P/E ratios suggest that many of these companies, including AZN, COP, PH, CNQ, VST, WBD, APD, DDOG, and ROK, are expected to achieve higher earnings growth than their respective industry averages. However, Becton, Dickinson (BDX) and TC Energy (TRP) show P/E ratios below or significantly below their industry averages, which may suggest different growth expectations or valuation dynamics. The varied P/E comparisons highlight sector-specific growth narratives.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment